Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
Exagen (Nasdaq: XGN) will release financial results for the quarter ended March 31, 2026, before the market opens on May 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exagen (Nasdaq: XGN) will release financial results for the quarter ended March 31, 2026, before the market opens on May 11, 2026.
John Aballi, President and CEO, and Jeff Black, CFO, will host a conference call and webcast at 8:30 a.m. ET (5:30 a.m. PT) that day. Webcast and replay will be available via the Exagen Investor Relations website; telephone replay available through May 25, 2026.
Details
News Market Reaction – XGN
On Apr 27, the day this news came out, XGN closed 1.48% above the previous close.
Data tracked by StockTitan Argus for the Apr 27 session.
Key Figures
- Earnings release date
- May 11, 2026
- Q1 2026 financial results to be released before market open
- Quarter end date
- March 31, 2026
- Quarter for which Exagen will report results
- Conference call time
- 8:30 a.m. ET
- Management call to review Q1 2026 results
- U.S. dial-in
- 877-407-0890
- Domestic access number for Q1 2026 earnings call
- International dial-in
- +1 201-389-0918
- International access number for Q1 2026 earnings call
- Replay end date
- May 25, 2026
- Telephone replay available until this date
- Replay passcode
- 13759736
- Passcode required to access telephone replay
Previous Earnings date Reports
-
Announced timing and access details for Q4 and full-year 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company’s results.
Conference Call & Webcast:
- U.S. dial-in: 877-407-0890
- International dial-in: +1 201-389-0918
- Webcast: Available via the Exagen Investor Relations website at investors.exagen.com
Replay: A telephone replay will be available until Monday, May 25, 2026:
- U.S. replay: 877-660-6853
- International replay: +1 201-612-7415
- Replay passcode: 13759736
- Webcast: A recording of the webcast will be available one hour after the call concludes via the Exagen Investor Relations website at investors.exagen.com
About Exagen Inc.
Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s disease earlier and with greater accuracy. Exagen’s CLIA-certified, CAP-accredited laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.
For more information, visit Exagen.com or follow Exagen on LinkedIn.
Contact
Tina Jacobsen, CFA
Exagen Inc.
ir@exagen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.